Dr. Charles H. Nash
Claim this profileNortheast Georgia Medical Center-Gainesville
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
20 reported clinical trials
55 drugs studied
About Charles H. Nash
Education:
- Obtained an MD from the University of Texas Health Science Center, San Antonio, Texas.
- Holds a Bachelor's degree from Jackson State University.
- Earned a Master's degree from the University of Southern Mississippi.
- Achieved a Doctoral degree from Mississippi State University.
Experience:
- Currently the Medical Director of the Cancer Center at Northeast Georgia Medical Center (NGMC).
- Practicing oncologist at The Longstreet Clinic Department of Medical Oncology and Hematology since 1999.
- Over 30 years of experience in oncology, with significant leadership roles in healthcare and academia.
Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
Stage II
2Non-Small Cell Lung Cancer
Global LeaderStage IV
MET positive
EGFR positive
Affiliated Hospitals
Clinical Trials Charles H. Nash is currently running
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Amivantamab
for Non-Small Cell Lung Cancer
This phase II Expanded Lung-MAP treatment trial tests how well amivantamab-subcutaneous (SC) works in treating patients patients with MET amplification non-small cell lung cancer. Amivantamab-SC is a drug that reduces extra copies of the MET gene, a change present in your tumor. Giving amivantamab-SC may lower the chance of the growth or spread of advanced non-small cell lung cancer that has extra copies of the MET gene in the tumor.
Recruiting1 award Phase 216 criteria
More about Charles H. Nash
Clinical Trial Related6 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Charles H. Nash has experience with
- Pembrolizumab
- Ramucirumab
- Abemaciclib
- Carboplatin
- Pemetrexed Disodium
- Gemcitabine Hydrochloride
Breakdown of trials Charles H. Nash has run
Lung Cancer
Non-Small Cell Lung Cancer
Pancreatic Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Charles H. Nash specialize in?
Charles H. Nash focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Charles H. Nash currently recruiting for clinical trials?
Yes, Charles H. Nash is currently recruiting for 7 clinical trials in Gainesville Georgia. If you're interested in participating, you should apply.
Are there any treatments that Charles H. Nash has studied deeply?
Yes, Charles H. Nash has studied treatments such as Pembrolizumab, Ramucirumab, Abemaciclib.
What is the best way to schedule an appointment with Charles H. Nash?
Apply for one of the trials that Charles H. Nash is conducting.
What is the office address of Charles H. Nash?
The office of Charles H. Nash is located at: Northeast Georgia Medical Center-Gainesville, Gainesville, Georgia 30501 United States. This is the address for their practice at the Northeast Georgia Medical Center-Gainesville.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.